Quoin Pharmaceuticals Ltd. Gains 36.15%
Fri, Jul 01, 2022 at 07:35 PM
Quoin Pharmaceuticals Ltd. (QNRX:NASDAQ) rocketted at $0.61, a gain of 36.2%. On Fri, Jul 01, 2022, QNRX:NASDAQ hit a New 2-Week High of $0.61. The stock appeared on our News Catalysts scanner on Wed, Jun 15, 2022 at 09:49 AM in the 'AGREEMENT' category. From Fri, Jun 17, 2022, the stock recorded 66.67% Up Days and 30.00% Green Days
The stock spiked on Fri, Jul 01, 2022 at $0.89 with a volume of 75M+.
About Quoin Pharmaceuticals Ltd. (QNRX:NASDAQ)
Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases.
Top 10 Gainers:
- Omeros Corporation (OMER:NASDAQ), 68.73%
- Clovis Oncology, Inc. (CLVS:NASDAQ), 58.33%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Fast Radius Inc. (FSRD:NASDAQ), 41.15%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 36.54%
- Quoin Pharmaceuticals Ltd. (QNRX:NASDAQ), 36.15%
- Inter & Co. Inc. (INTR:NASDAQ), 31.9%
- Shift Technologies Inc. (SFT:NASDAQ), 28.9%
- Accolade Inc. (ACCD:NASDAQ), 28.78%
- Mega Matrix Corp Com (MTMT:NYSEMKT), 25.74%